Qulipta (Atogepant)

Qulipta (Atogepant)

Qulipta

Atogepant

Tablets: 10 mg/30 mg/60 mg

AbbVie Inc.

Medical Use

Qulipta contains the active ingredient Atogepant, a calcitonin gene-related peptide receptor antagonist, used to prevent episodic migraines in adults.

Dosage Instructions:

  • -The recommended dosage is 10 mg, 30 mg, or 60 mg taken orally once daily, with or without food.
  • -The maximum daily dose is 60 mg.
  • -Swallow the tablets whole without chewing or crushing them.
  • -Follow your healthcare provider’s instructions precisely.

Special Dosage for Renal Impairment:

  • -For individuals with severe renal impairment or end-stage renal disease, the recommended dose is 10 mg taken orally once daily.

Missed Dose Instructions:

  • -If you miss a dose, take it as soon as you remember.
  • -If it’s almost time for your next dose, skip the missed dose and take the next one at the regular time.
  • -Do not take an extra dose to make up for the missed one.